Patients face a risk of adverse events if they mistakenly take the wrong medication, according to a new warning from the FDA. 

The new meta-analysis, published in Frontiers in Cardiovascular Medicine, included data from 58 million patients. “We hope our findings will help mitigate vaccine hesitancy and increase vaccine uptake," one researcher said. 

"Our findings indicate that drinking modest amounts of coffee of all types should not be discouraged but can be enjoyed as a heart-healthy behavior," said a cardiologist involved in the study. 

A team of specialists from Cleveland Clinic reviewed nearly 3,000 medications, writing that a common type 2 diabetes medication offered the most potential as an effective treatment for AFib. 

Back in May, tirzepatide was approved by the FDA for improving glycemic control among adults with type 2 diabetes.